Memphis Pharmaceutical
MPCI
1.10%
100.92
1.10
MPCI
The board of Memphis Co. for Pharmaceutical & Chemical Industries endorsed financial indicators for the fiscal year that ended on June 30, 2014, after the adjustments of the Central Auditing Organization (CAO).
These indicators showed EGP 900 thousand net profit before tax, with a drop by 84% compared with EGP 5.5 million in FY12/13.
The drug manufacturer had reported EGP 1 million net loss before tax for the 11-month period from July 1, 2013 till May 31, 2014, against EGP 3.5 million net profit in the year-ago period.
These indicators showed EGP 900 thousand net profit before tax, with a drop by 84% compared with EGP 5.5 million in FY12/13.
The drug manufacturer had reported EGP 1 million net loss before tax for the 11-month period from July 1, 2013 till May 31, 2014, against EGP 3.5 million net profit in the year-ago period.
Source:
Mubasher